Decision to list Medical Devices supplied by Device Technologies New Zealand Limited, Medipak Surgical NZ Limited and Draeger New Zealand Limited

Hospital devices

Decision

We are pleased to announce the approval of individual listing agreements with Device Technologies, Medipak Surgical NZ and Draeger New Zealand for the supply of medical devices to DHB Hospitals.

What we’re doing

We are pleased to announce the approval of individual listing Agreements with three suppliers for the supply of medical devices to DHB Hospitals as follows:

Supplier Category
Device Technologies New Zealand Limited (“Device Technologies”)
  • Respiratory equipment and consumables devices (“Respiratory Care Products”)
Medipak Surgical NZ Limited (“Medipak”)
  • Anaesthesia small equipment and consumable devices (“Anaesthesia Products”)
Draeger New Zealand Limited (“Draeger”)
  • Respiratory Care Products
  • Anaesthesia Products

This will result in Pharmaceutical Schedule listings for 46 products from Device Technologies, 66 products from Medipak and 86 products from Draeger.

Brand ranges in the Agreements include:

Device Technologies Medipak Draeger

Respiratory Care Products

ProBreathe

Flexicare

Anaesthesia Products

Karl Storz

Anaesthesia Products

Drager

Drager DragerSorb

Respiratory Care Products

Drager CareStar

Drager Pack2Go

Drager SafeStar

Drager TwinStar

Drager VentStar

Drager VentStar Helix

Any changes to the original proposal?

This decision was subject to consultation letters dated 25 July 2018 and 13 August 2018.

In response to consultation feedback received, PHARMAC and Medipak renegotiated specific terms and conditions of the proposed agreement. No changes were made to the Device Technologies or Draeger listing agreements as a result of consultation feedback.

Who we think will be most interested

  • Suppliers and Wholesalers
  • DHB Staff
    • Clinical Engineers
    • Anaesthetists and Anaesthetic Technicians
    • Clinical staff involved with airway management and emergency respiratory resuscitation
    • Respiratory Clinicians
    • Respiratory therapists
    • Pulmonary function specialists
    • Pulmonary rehabilitation specialists
    • Clinical staff working in surgical and medical units, emergency departments, intensive and critical care units, and outpatient units
    • District nurses
    • Procurement Officers

Detail about this decision

In 2017 PHARMAC issued Requests for Proposals (“RFPs”) for Respiratory Care Products and Anaesthesia Products. These RFPs were for non-exclusive national agreements for listing in the Pharmaceutical Schedule.

After completing the RFP evaluation processes and consulting on the provisional Agreements reached with Device Technologies, Medipak and Draeger, PHARMAC has decided to list ranges of their medical devices in Part III of Section H of the Pharmaceutical Schedule.

The medical devices listed under these national agreements will be available on PHARMAC's website from 1 October 2018, in both a PDF document and an Excel spreadsheet.

DHB hospitals would continue to be able to choose which Anaesthesia Products and Respiratory Care Products they purchase, however would need to use these agreements should they choose to purchase Device Technologies, Medipak or Draeger medical devices listed in the Pharmaceutical Schedule, effective from 1 October 2018.  

All three companies have some products that are new to New Zealand DHBs and the Agreements would provide an increased range of devices from which clinicians could choose.

Pricing for the Anaesthesia Products and Respiratory Care Products, subject to any prior termination of the Agreements, would not be increased without prior consultation and approval by PHARMAC.

Device Technologies, Medipak and Draeger will provide training and education services that will be tailored to suit the needs of individual DHBs in formats and at times as required by DHBs.

We intend to consult on proposed agreements for Anaesthesia Products and Respiratory Care Products with additional suppliers over the next few months.

Our response to what you told us

We appreciate the time people took to consider this consultation.

All consultation responses received were considered in their entirety in making a decision to approve the Device Technologies, Medipak and Draeger provisional Agreements.

A summary of the main themes raised in feedback and our responses to the feedback received are set out below:

Theme Comment
Feedback that no technical or resource impacts are expected as a result of the proposal. Noted.
Feedback from one DHB regarding the proposed minimum shelf life of medical devices at time of delivery. PHARMAC renegotiated the shelf life of medical devices at the time of delivery with Medipak.
Feedback that the respondents do not have a good understanding of the merits of many of the proposed products and are not in a position to form a judgement on the products or to know whether there are better products that would be preferable to include. Noted.

If you have any questions about this decision, you can email us at enquiry@pharmac.govt.nz; or call our toll free number (9 am to 5 pm, Monday to Friday) on 0800 66 00 50.